Literature DB >> 23834551

Sex differences in negative affect and lapse behavior during acute tobacco abstinence: a laboratory study.

Raina D Pang1, Adam M Leventhal.   

Abstract

Heightened negative affect during acute tobacco abstinence in women relative to men could be an important factor underlying sex differences in smoking motivation. However, little controlled experimental work addresses this hypothesis. The current study investigated sex differences in withdrawal-related negative affect, time to start smoking on a lab analogue smoking lapse task, and the interrelation between sex, withdrawal-related negative affect, and smoking lapse behavior. Following a baseline session, current smokers (women: n = 68, men: n = 131) attended two counterbalanced lab sessions (16 hours smoking abstinence and ad libitum smoking) during which they completed self-report measures of mood and withdrawal symptoms followed by a laboratory analogue smoking lapse task. In this task participants are monetarily rewarded for delaying smoking. Performance on this task serves as an analogue model of smoking lapse behavior by measuring smoker's capability to resist temptation to smoke under conditions where abstinence is advantageous. Females showed greater abstinence induced increases in composite negative affect as well as several particular negative affect states (i.e., POMS Anger, Anxiety, Depression, and Confusion, ps < .05) but no differences in abstinence induced changes in other forms of affect or craving. Females also exhibited marginally greater abstinence induced decreases in their willingness to delay smoking for money (p = .10), which was mediated by abstinence induced increases in anger (p < .05). These results suggest that differential sensitivity to abstinence induced negative affect, particularly anger, could underlie sex specific smoking patterns. Negative affect during tobacco abstinence may be an important factor for understanding and treating nicotine addiction in women. PsycINFO Database Record (c) 2013 APA, all rights reserved

Entities:  

Mesh:

Year:  2013        PMID: 23834551      PMCID: PMC3962304          DOI: 10.1037/a0033429

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  48 in total

Review 1.  Effects of abstinence from tobacco: valid symptoms and time course.

Authors:  John R Hughes
Journal:  Nicotine Tob Res       Date:  2007-03       Impact factor: 4.244

2.  Distribution of the product confidence limits for the indirect effect: program PRODCLIN.

Authors:  David P MacKinnon; Matthew S Fritz; Jason Williams; Chondra M Lockwood
Journal:  Behav Res Methods       Date:  2007-08

3.  Increase in anger symptoms after smoking cessation predicts relapse.

Authors:  Freda Patterson; Kia Kerrin; E Paul Wileyto; Caryn Lerman
Journal:  Drug Alcohol Depend       Date:  2008-03-06       Impact factor: 4.492

4.  Craving, withdrawal, and smoking urges on days immediately prior to smoking relapse.

Authors:  Sharon S Allen; Tracy Bade; Dorothy Hatsukami; Bruce Center
Journal:  Nicotine Tob Res       Date:  2008-01       Impact factor: 4.244

Review 5.  Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung.

Authors:  Alan B Shafer
Journal:  J Clin Psychol       Date:  2006-01

6.  Nicotine withdrawal symptoms in adolescent and adult twins.

Authors:  Michele L Pergadia; Arpana Agrawal; Andrew C Heath; Nicholas G Martin; Kathleen K Bucholz; Pamela A F Madden
Journal:  Twin Res Hum Genet       Date:  2010-08       Impact factor: 1.587

7.  Gender differences in acute tobacco withdrawal: effects on subjective, cognitive, and physiological measures.

Authors:  Adam M Leventhal; Andrew J Waters; Susan Boyd; Eric T Moolchan; Caryn Lerman; Wallace B Pickworth
Journal:  Exp Clin Psychopharmacol       Date:  2007-02       Impact factor: 3.157

8.  Gender effects on mood and cigarette craving during early abstinence and resumption of smoking.

Authors:  Jiansong Xu; Allen Azizian; John Monterosso; Catherine P Domier; Arthur L Brody; Timothy W Fong; Edythe D London
Journal:  Nicotine Tob Res       Date:  2008-11       Impact factor: 4.244

9.  Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence.

Authors:  Timothy B Baker; Megan E Piper; Danielle E McCarthy; Daniel M Bolt; Stevens S Smith; Su-Young Kim; Suzanne Colby; David Conti; Gary A Giovino; Dorothy Hatsukami; Andrew Hyland; Suchitra Krishnan-Sarin; Raymond Niaura; Kenneth A Perkins; Benjamin A Toll
Journal:  Nicotine Tob Res       Date:  2007-11       Impact factor: 4.244

10.  Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: a retrospective analysis.

Authors:  Teresa R Franklin; Ronald Ehrman; Kevin G Lynch; Derek Harper; Nathan Sciortino; Charles P O'Brien; Anna Rose Childress
Journal:  J Womens Health (Larchmt)       Date:  2008-03       Impact factor: 2.681

View more
  37 in total

1.  Gender differences in self-reported withdrawal symptoms and reducing or quitting smoking three years later: A prospective, longitudinal examination of U.S. adults.

Authors:  Andrea H Weinberger; Jonathan M Platt; Jonathan Shuter; Renee D Goodwin
Journal:  Drug Alcohol Depend       Date:  2016-06-20       Impact factor: 4.492

2.  Variability in nicotine conditioned place preference and stress-induced reinstatement in mice: Effects of sex, initial chamber preference, and guanfacine.

Authors:  Angela M Lee; Cali A Calarco; Sherry A McKee; Yann S Mineur; Marina R Picciotto
Journal:  Genes Brain Behav       Date:  2019-08-13       Impact factor: 3.449

3.  Gender differences in negative reinforcement smoking expectancies.

Authors:  Raina D Pang; Michael J Zvolensky; Norman B Schmidt; Adam M Leventhal
Journal:  Nicotine Tob Res       Date:  2014-10-25       Impact factor: 4.244

4.  Sex Differences in Subjective and Behavioral Responses to Stressful and Smoking Cues Presented in the Natural Environment of Smokers.

Authors:  Rachel L Tomko; Michael E Saladin; Nathaniel L Baker; Erin A McClure; Matthew J Carpenter; Viswanathan R Ramakrishnan; Bryan W Heckman; Jennifer M Wray; Katherine T Foster; Stephen T Tiffany; Christopher L Metts; Kevin M Gray
Journal:  Nicotine Tob Res       Date:  2020-01-27       Impact factor: 4.244

Review 5.  Consideration of sex in clinical trials of transdermal nicotine patch: a systematic review.

Authors:  Andrea H Weinberger; Philip H Smith; Mira Kaufman; Sherry A McKee
Journal:  Exp Clin Psychopharmacol       Date:  2014-08-18       Impact factor: 3.157

6.  Posttraumatic stress symptoms and tobacco abstinence effects in a non-clinical sample: evaluating the mediating role of negative affect reduction smoking expectancies.

Authors:  Kirsten J Langdon; Adam M Leventhal
Journal:  J Psychopharmacol       Date:  2014-08-20       Impact factor: 4.153

Review 7.  Sex Differences in Tobacco Use Among Persons Living With HIV/AIDS: A Systematic Review and Meta-Analysis.

Authors:  Andrea H Weinberger; Philip H Smith; Allison P Funk; Shayna Rabin; Jonathan Shuter
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-01       Impact factor: 3.731

8.  Sex differences in resting state neural networks of nicotine-dependent cigarette smokers.

Authors:  Reagan R Wetherill; Kanchana Jagannathan; Joshua Shin; Teresa R Franklin
Journal:  Addict Behav       Date:  2014-01-24       Impact factor: 3.913

Review 9.  Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation.

Authors:  Andrea H Weinberger; Philip H Smith; Sharon S Allen; Kelly P Cosgrove; Michael E Saladin; Kevin M Gray; Carolyn M Mazure; Cora Lee Wetherington; Sherry A McKee
Journal:  Nicotine Tob Res       Date:  2015-04       Impact factor: 4.244

10.  Ovarian Hormones and Transdermal Nicotine Administration Independently and Synergistically Suppress Tobacco Withdrawal Symptoms and Smoking Reinstatement in the Human Laboratory.

Authors:  Raina D Pang; Madalyn M Liautaud; Matthew G Kirkpatrick; Jimi Huh; John Monterosso; Adam M Leventhal
Journal:  Neuropsychopharmacology       Date:  2017-09-14       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.